About Sequence Biotech Private Limited
Data last updated:
Sequence Biotech Private Limited is a private limited company based in Nashik, Maharashtra, India. It operates in the fertilizers and soil enhancers segment of the agriculture sector. It was incorporated on 19 September 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2008PTC186895. Its GSTIN is 27AAMCS5184L1ZM (Maharashtra).
The company has an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹1.92 Cr. It is led by directors including Rajendra Jaising Patil and Sunita Narendra Aghav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gat No. 208 Post Wadiwarhe Tal. Igatpuri Dist. Nashik, Maharashtra, India – 422403.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.19 Cr, a decline of 27% compared to the previous year. For the same year it recorded a net profit of ₹21.91 Lakh (net margin 10%) and EBITDA of ₹1.16 Cr (EBITDA margin 53%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 16% over five years.
The company has about 6 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹6.02 Cr on record. Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sequencebiotech.in.
Company details
Contact details
Sequence Biotech Private Limited's registered office is in Nashik, Maharashtra. Its website is sequencebiotech.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressGat No. 208 Post Wadiwarhe Tal. Igatpuri Dist. Nashik, Maharashtra, India – 422403
- IndustryAgriculture, Fertilizers & Soil Enhancers
To see the full contact details of Sequence Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sequence Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sequence Biotech Private Limited, buy the company report.
Financials of Sequence Biotech Private Limited
FY 2025 filings availableSequence Biotech Private Limited reported revenue of ₹2.19 Cr (down 27% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 27% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 16%. EBITDA fell 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.16 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹21.91 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 53% | ||||
| Net Profit Margin | 10% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sequence Biotech Private Limited, buy the company report.
Board of directors of Sequence Biotech Private Limited
Sequence Biotech has 5 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajendra Jaising Patil | Director | 19 Sep 2008 | 18 Years 1 Months | Current |
| Sunita Narendra Aghav | Director | 19 Sep 2008 | 18 Years 1 Months | Current |
| Shriram Ganesh Bhalerao | Director | 02 Dec 2010 | 15 Years 11 Months | Current |
| Shrikant Shankar Bapat | Director | 02 Dec 2010 | 15 Years 11 Months | Current |
| Vijay Madhusudhan Bibikar | Director | 02 Dec 2010 | 15 Years 11 Months | Current |
Auditor
Sequence Biotech Private Limited is audited by GHANSHAM GAJANAN YEOLA for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GHANSHAM GAJANAN YEOLA | FY 2023 | 101310 |
Shareholding
The shareholding of Sequence Biotech Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sequence Biotech Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Nov 2024 | 101006403 | Others | ₹20.35 Lakh | Open | |
| 27 Sep 2024 | 101007565 | Others | ₹41.49 Lakh | Open | |
| 09 Jun 2011 | 10298913 | Bank of Maharashtra | ₹5.4 Cr | Open |
To see the full charge records of Sequence Biotech Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Sequence Biotech Private Limited has 1 court case on record: 1 filed by Sequence Biotech. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Writ petition | Filed by the company against The Collector Nashik THR Its Tenancy Dept | Disposed |
To see the full case history of Sequence Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sequence Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Sequence Biotech Private Limited has a workforce of 6 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 6 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 |
To see the full employee and EPFO history of Sequence Biotech Private Limited, buy the company report.
GST
Sequence Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAMCS5184L1ZM | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sequence Biotech Private Limited, buy the company report.
Recent activity
Sequence Biotech Private Limited has 8 board changes on record since 2008: 5 appointments and 3 cessations. The latest: Virendra Sitaram Upadhye ceased to be Director on 07 Jun 2022.
4 earlier events are in the company report.
Frequently asked questions
Sequence Biotech is an active private limited company based in Nashik, Maharashtra, India. The company works in fertilizers and soil enhancers, within the agriculture industry. It was incorporated on 19 September 2008 (18+ years old) and is registered under CIN U74999MH2008PTC186895.
Sequence Biotech has 5 current directors:
- Rajendra Jaising Patil - Director
- Sunita Narendra Aghav - Director
- Shriram Ganesh Bhalerao - Director
- Shrikant Shankar Bapat - Director
- Vijay Madhusudhan Bibikar - Director
The latest financial statements of Sequence Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sequence Biotech is 27AAMCS5184L1ZM, registered in Maharashtra.
The CIN (Corporate Identification Number) of Sequence Biotech is U74999MH2008PTC186895. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sequence Biotech has 1 court case on record: 1 filed by the company.
Sequence Biotech was incorporated on 19 September 2008, making it 18+ years old. It is registered with the Registrar of Companies, Mumbai.
Virendra Sitaram Upadhye ceased to be Director on 07 Jun 2022. Alka Rajendra Patil ceased to be Director on 02 Dec 2010. Ashwini Gokul Wagh ceased to be Director on 02 Dec 2010. Sequence Biotech has 8 board changes on record in total.
Sequence Biotech can be reached through the website sequencebiotech.in. Its registered office is in Nashik, Maharashtra, India.
The registered office of Sequence Biotech is at Gat No. 208 Post Wadiwarhe Tal. Igatpuri Dist. Nashik, Maharashtra, India – 422403.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
